Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-12-01T06:01:17.652Z Has data issue: false hasContentIssue false
  • English
  • Français

A case-control study of vitamin D status and asthma in adults

Published online by Cambridge University Press:  19 November 2010

K. Allan ,
G. Devereux ,
G. McNeill ,
A. Wilson ,
A. Avenell  and
W. Fraser
K. Allan
Affiliation:
Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
G. Devereux
Affiliation:
Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
G. McNeill
Affiliation:
Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
A. Wilson
Affiliation:
Biomedicine Group, School of Medicine, University of East Anglia, Norwich, NR4 7TJ, UK
A. Avenell
Affiliation:
Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
W. Fraser
Affiliation:
Metabolic Bone Diseases Unit, Department of Clinical Chemistry, University of Liverpool, Duncan Building, Daulby St, Liverpool L69 3GA, UK
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 69 , Issue OCE6: Summer Meeting, 28 June–1 July 2010, Nutrition and health: cell to community , 2010 , E475
Copyright
Copyright © The Authors 2010

It has been suggested that the rapid increase in the prevalence of asthma in developed countries in recent decades may be the result of changes in diet and lifestyle(Reference Devereux1). Asthma is associated with an alteration in the balance of T-helper lymphocytes with an increase in pro-inflammatory Th2 cells. As vitamin D may directly suppress Th2 differentiation(Reference Jirapongsananuruk, Melamed and Leung2, Reference Urry, Xystrakis and Richards3), it has been hypothesised that low vitamin D status, as a consequence of sun avoidance behaviours and an increasingly indoor lifestyle, could contribute to the rising prevalence of asthma(Reference Litonjua and Weiss4).

The present study was designed to compare the vitamin D status of age and sex-matched adults with and without physician-confirmed asthma. The study was conducted in the Chest Clinic, Aberdeen Royal Infirmary and the Department of Respiratory Medicine; Norfolk and Norwich University Hospital, Norfolk. One hundred and sixty participants aged between 18 and 50 years were recruited, 80 with physician-confirmed mild/moderate asthma and 80 age and gender-matched controls. Cases and controls were assessed within a month of each other to control for seasonal variation of sunlight exposure. Controls were individuals without asthma who had a smoking history of <10 pack-years. The majority of controls (70%) were recruited from local daycase surgery units, the remainder bring recruited after advertising in local press. Ninety-four participants were recruited in Aberdeen between June 2007 and April 2008, and 66 in Norwich between October 2007 and September 2008. Vitamin D status was assessed by serum 25-hydroxyvitamin D3 measured by HPLC-tandem mass spectrometry.

Mean serum 25-hydroxyvitamin D3 concentration was 8.68 ng/ml (95% CI 7.60, 9.75), being lower in Aberdeen 6.78 ng/ml (95% CI 5.32, 8.25) than Norwich 11.5 ng/ml (95% CI 10.2, 12.8). In Aberdeen, 76% of the participants had serum levels below the generally accepted cut-off for a deficiency of 10 ng/ml(Reference Devereux, MacDonald and Hawrylowicz5). In Norwich, this figure was 42%. In winter (December–February), these proportions rose to 92.3% and 46.4%, respectively. There was no significant difference in the serum 25-hydroxyvitamin D3 concentrations between cases and controls: 8.50 ng/ml (95% CI 7.06, 9.95) v. 8.86 (95% CI 7.22, 10.5). Conditional logistic regression adjusting serum 25-hydroxyvitamin D3 levels for age, gender, smoking status, BMI and season of assessment revealed no difference in serum 25-hydroxyvitamin D3 levels between cases and controls (OR asthma v. control 0.98 (95% CI 0.91, 1.04), P=0.50). Similar multivariable analysis demonstrated association neither between 25-hydroxyvitamin D3 levels and asthma severity nor lung function (FEV1 % predicted).

This study does not find evidence to support the use of vitamin D as an adjunct to conventional therapy in asthma in adults.

This study was funded by NHS Grampian Endowment Funds.

References

1.Devereux, G (2006) The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol 6, 869–874.CrossRefGoogle ScholarPubMed
2.Jirapongsananuruk, O, Melamed, I & Leung, DY (2000) Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 106, 981–985.CrossRefGoogle Scholar
3.Urry, Z, Xystrakis, E, Richards, DF et al. (2009) Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 119, 387–398.Google ScholarPubMed
4.Litonjua, AA & Weiss, ST (2007) Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 120, 1031–1035.CrossRefGoogle ScholarPubMed
5.Devereux, G, MacDonald, H & Hawrylowicz, C (2009) Vitamin D and asthma time for intervention? Am J Respir Crit Care Med 179, 739–742.CrossRefGoogle ScholarPubMed